Evidence map›Paper›PMID 41154268›Full record

ArticleHealthcare (Basel, Switzerland)2025

Quantitatively Evaluate the Improvement of Functional Cure for the Quality of Life of Chronic Hepatitis B Cases: Evidence from a Cross-Sectional Study in China.

Sihui Zhang, Zhiliang Gao, Hui Li, Yi Kang, Lei Fu, Xuebing Chen, Xiaoyuan Xu, Xinyue Chen, Hui Zhuang, Hui Zheng and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sihui ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.ORCID 0000-0002-5459-1630
Zhiliang GaoThe Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China.
Hui LiThe Second People's Hospital of Yunnan Province, Kunming 650251, China.
Yi KangHenan Provincial People's Hospital, Zhengzhou 450000, China.
Lei FuXiangya Hospital, Central South University, Changsha 410008, China.ORCID 0000-0001-7550-1254
Xuebing ChenPeople's Hospital of Deyang City, Deyang 618000, China.
Xiaoyuan XuDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.ORCID 0000-0002-1759-4330
Xinyue ChenDepartment of Hepatology, Beijing Institute of Hepatology, Beijing You'an Hospital, Capital Medical University, Beijing 100052, China.ORCID 0000-0003-3212-2398
Hui ZhuangDepartment of Microbiology and Centre for Infectious Disease, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Hui ZhengNational Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Fuqiang CuiDepartment of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

functional curehealth-related quality of life (HRQoL)Hepatitis Bquantitative analysis

Identifiers

PMID41154268
PMCPMC12564838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.